Effect of body mass index and abdominal obesity on mortality after percutaneous coronary intervention: a nationwide, population-based study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: We investigated the impact of obesity on the clinical outcomes following percutaneous coronary intervention (PCI). Methods: We included South Koreans aged > 20 years who underwent the Korean National Health Screening assessment between 2009 and 2012. Obesity was defined using the body mass index (BMI), according to the World Health Organization’s recommendations. Abdominal obesity was defined using the waist circumference (WC), as defined by the Korean Society for Obesity. The odds and hazard ratios in all-cause mortality were calculated after adjustment for multiple covariates. Patients were followed up to the end of 2017. Results: Among 130,490 subjects who underwent PCI, the mean age negatively correlated with BMI. WC, hypertension, diabetes, dyslipidemia, fasting glucose, total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels correlated with the increased BMI. The mortality rates were higher in the lower BMI and WC groups than the higher BMI and WC groups. The non-obese with abdominal obesity group showed a mortality rate of 2.11 per 1,000 person-years. Obese with no abdominal obesity group had the lowest mortality rate (0.88 per 1,000 person-years). The mortality showed U-shaped curve with a cut-off value of 29 in case of BMI and 78 cm of WC. Conclusions: The mortality showed U-shaped curve and the cut-off value of lowest mortality was 29 in case of BMI and 78 cm of WC. The abdominal obesity may be associated with poor prognosis in Korean patients who underwent PCI.
Abstract
Background/Aims: We investigated the impact of obesity on the clinical outcomes following percutaneous coronary intervention (PCI). Methods: We included South Koreans aged > 20 years who underwent the Korean National Health Screening assessment between 2009 and 2012. Obesity was defined using the body mass index (BMI), according to the World Health Organization’s recommendations. Abdominal obesity was defined using the waist circumference (WC), as defined by the Korean Society for Obesity. The odds and hazard ratios in all-cause mortality were calculated after adjustment for multiple covariates. Patients were followed up to the end of 2017. Results: Among 130,490 subjects who underwent PCI, the mean age negatively correlated with BMI. WC, hypertension, diabetes, dyslipidemia, fasting glucose, total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels correlated with the increased BMI. The mortality rates were higher in the lower BMI and WC groups than the higher BMI and WC groups. The non-obese with abdominal obesity group showed a mortality rate of 2.11 per 1,000 person-years. Obese with no abdominal obesity group had the lowest mortality rate (0.88 per 1,000 person-years). The mortality showed U-shaped curve with a cut-off value of 29 in case of BMI and 78 cm of WC. Conclusions: The mortality showed U-shaped curve and the cut-off value of lowest mortality was 29 in case of BMI and 78 cm of WC. The abdominal obesity may be associated with poor prognosis in Korean patients who underwent PCI.
참고문헌 (30)
- Yoon KH, "Epidemic obesity and type 2 diabetes in Asia", Lancet, 368, pp.1681~1688 (2006)
- Patterson RE, "A comprehensive examination of health conditions associated with obesity in older adults", Am J Prev Med, 27, pp.385~390 (2004)
- An R, "Global warming and obesity : a systematic review", Obes Rev, 19, pp.150~163 (2018)
- Alexander CM, "NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older", Diabetes, 52, pp.1210~1214 (2003)
- Bays HE, "Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity", Expert Rev Cardiovasc Ther, 6, pp.343~368 (2008)
- Prospective Studies Collaboration, "Body-mass index and cause-specific mortality in 900 000 adults : collaborative analyses of 57 prospective studies", Lancet, 373, pp.1083~1096 (2009)
- Manson JE, "A prospective study of obesity and risk of coronary heart disease in women", N Engl J Med, 322, pp.882~889 (1990)
- Nordestgaard BG, "The effect of elevated body mass index on ischemic heart disease risk : causal estimates from a Mendelian randomisation approach", PLoS Med, 9, pp.e1001212~ (2012)
- Ramachandran A, "Obesity in Asia : is it different from rest of the world", Diabetes Metab Res Rev, 28(Suppl 2), pp.47~51 (2012)
- Ellis SG, "Low-normal or excessive body mass index : newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention", Am J Cardiol, 78, pp.642~646 (1996)
- Gruberg L, "The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?", J Am Coll Cardiol, 39, pp.578~584 (2002)
- Dhoot J, "Effect of morbid obesity on in-hospital mortality and coronary revascularization outcomes after acute myocardial infarction in the United States", Am J Cardiol, 111, pp.1104~1110 (2013)
- Oreopoulos A, "Effect of obesity on short- and longterm mortality postcoronary revascularization: a meta-analysis", Obesity(Silver Spring), 16, pp.442~450 (2008)
- Mathieu P, "Visceral obesity and the heart", Int J Biochem Cell Biol, 40, pp.821~836 (2008)
- Browning LM, "A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes : 0. 5 could be a suitable global boundary value", Nutr Res Rev, 23, pp.247~269 (2010)
- Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation, "World Health Organization", World Health Organization, ~ (2011)
- World Health Organization, "The Asia-Pacific Perspective: Redefining Obesity and Its Treatment" (2000), Health Communications Australia
- 윤연석, "Optimal Waist Circumference Cutoff Values for the Diagnosis of Abdominal Obesity in Korean Adult", Endocrinology and Metabolism, 29(4), pp.418~426 (2014), 대한내분비학회
- Kim S, "Normal-weight obesity is associated with increased risk of subclinical atherosclerosis", Cardiovasc Diabetol, 14, pp.58~ (2015)
- Ryo M, "Clinical significance of visceral adiposity assessed by computed tomography : a Japanese perspective", World J Radiol, 6, pp.409~416 (2014)
- Kassi E, "Metabolic syndrome : definitions and controversies", BMC Med, 9, pp.48~ (2011)
- Lim S, "Ectopic fat and cardiometabolic and vascular risk", Int J Cardiol, 169, pp.166~176 (2013)
- Kadakia MB, "Central obesity and cardiovascular outcomes in patients with acute coronary syndrome : observations from the MERLIN-TIMI 36 trial", Heart, 97, pp.1782~1787 (2011)
- Coutinho T, "Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease : role of"normal weight central obesity"", J Am Coll Cardiol, 61, pp.553~560 (2013)
- Park SJ, "Impact of body fat distribution on long-term clinical outcomes after drug-eluting stent implantation", PLoS One, 13, pp.e0197991~ (2018)
- Alexopoulos N, "Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis", Atherosclerosis, 233, pp.104~112 (2014)
- Ragino YI, "The role of secretory activity molecules of visceral adipocytes in abdominal obesity in the development of cardiovascular disease : a review", Biomolecules, 10, pp.374~ (2020)
- Numasawa Y, "Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry", PLoS One, 10, pp.e0124399~ (2015)
- Azhari Z, "Association between body mass index and outcomes after percutaneous coronary intervention in multiethnic South East Asian population : a retrospective analysis of the Malaysian National Cardiovascular Disease Database-Percutaneous Coronary Intervention(NCVD-PCI)registry", BMJ Open, 7, pp.e017794~ (2017)
- Mongraw-Chaffin ML, "The sex-specific association between BMI and coronary heart disease : a systematic review and meta-analysis of 95 cohorts with 1·2 million participants", Lancet Diabetes Endocrinol, 3, pp.437~449 (2015)